ABBV vs TSLA: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$372.11
+45.0% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
TSLA has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
TSLA |
| Current Price |
$261.70 |
$372.11 |
| Fair Value Estimate |
$259.04 |
$539.56 |
| Upside to Fair Value |
-1.0%
|
+45.0%
|
| Market Cap |
$462.4B |
$1,469.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
121.7x
|
| Price / Sales |
7.2x
|
14.2x
|
| Price / FCF |
23.6x
|
209.1x
|
| Revenue Growth YoY |
+10.2%
|
+25.5%
|
| Gross Margin |
71.5%
|
18.9%
|
| Operating Margin |
29.3%
|
4.2%
|
| Return on Equity |
-136.5%
|
4.6%
|
| Dividend Yield |
2.61% |
0% |
| FCF Yield |
4.25%
|
0.48%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Tesla, Inc. designs, manufactures and sells electric vehicles and energy generation and storage systems, operating through Automotive and Energy Generation and Storage segments with 134,785 full-time employees and a market capitalization of $1,469.67 billion at a share price of $372.11. The business quality is mixed: revenue grew 25.5% year over year in the most recent quarter, but earnings fell …
Accumulation Zones
| Metric |
ABBV |
TSLA |
| Zone Low |
$194.28 |
$404.67 |
| Zone High |
$220.18 |
$458.63 |
| In Buy Zone? |
No
|
Yes
|